Stat3 and Stat4 direct development of IL-17-secreting Th cells

被引:426
|
作者
Mathur, Anubhav N.
Chang, Hua-Chen
Zisoulis, Dimitrios G.
Stritesky, Gretta L.
Yu, Qing
O'Malley, John T.
Kapur, Reuben
Levy, David E.
Kansas, Geoffrey S.
Kaplan, Mark H.
机构
[1] Indiana Univ, Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA
[3] Indiana Univ, Sch Med, Walther Canc Inst, Indianapolis, IN 46202 USA
[4] Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA
[5] NYU, Sch Med, Dept Pathol & Microbiol, New York, NY 10016 USA
来源
JOURNAL OF IMMUNOLOGY | 2007年 / 178卷 / 08期
关键词
D O I
10.4049/jimmunol.178.8.4901
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-17-secreting CD4(+) T cells are critically involved in inflammatory immune responses. Development of these cells is promoted in vivo and in vitro by IL-23 or TGF beta 1 plus IL-6. Despite growing interest in this inflammatory Th subset, little is known about the transcription factors that are required for their development. We demonstrate that Stat3 is required for programming the TGF beta 1 plus IL-6 and IL-23-stimulated IL-17-secreting phenotype, as well as for ROR gamma t expression in TGF beta 1 plus IL-6-primed cells. Moreover, retroviral transduction of a constitutively active Stat3 into differentiating T cell cultures enhances IL-17 production from these cells. We further show that Stat4 is partially required for the development of IL-23-, but not TGF beta 1 plus IL-6-primed IL-17-secreting cells, and is absolutely required for IL-17 production in response to IL-23 plus IL-18. The requirements for Stat3 and Stat4 in the development of these IL-17-secreting subsets reveal additional mechanisms in Th cell fate decisions during the generation of proinflammatory cell types.
引用
收藏
页码:4901 / 4907
页数:7
相关论文
共 50 条
  • [41] Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells
    Ghandil, P.
    Chrabieh, M.
    Feinberg, J.
    Von Bernuth, H.
    Picard, C.
    Casanova, J. L.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 154 : 19 - 19
  • [42] IL-27 inhibits the development of regulatory T cells via STAT3
    Huber, M.
    Steinwald, V.
    Guralnik, A.
    Bruestle, A.
    Kleemann, P.
    Rosenplaenter, C.
    Decker, T.
    Lohoff, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 45 - 45
  • [43] IL-10 ACTIVATES STAT1 AND STAT3
    WEBERNORDT, RM
    GREENLUND, AC
    MOORE, KW
    DARNELL, JE
    SCHREIER, RD
    FASEB JOURNAL, 1995, 9 (04): : A772 - A772
  • [44] IL-23 DRIVES PATHOGENIC TH17 CELLS THROUGH EPIGENETIC REGULATION BY STAT3 IN SLE PATIENTS
    Seunghyun, Lee
    Nakayamada, Shingo
    Kubo, Satoshi
    Kaoru, Yamagata
    Yukihiro, Kitanaga
    Tanaka, Yoshiya
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1069 - 1069
  • [45] Attenuation of Intraocular Inflammatory Responses in Experimental Autoimmune Uveitis by TMP Is Associated with Modulating of the STAT3 and STAT4 Pathways
    Lei, Bo
    Lin, Ru
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [46] Silibinin is a direct inhibitor of STAT3
    Verdura, Sara
    Cuyas, Elisabet
    Llorach-Pares, Laura
    Perez-Sanchez, Almudena
    Micol, Vicente
    Nonell-Canals, Alfons
    Joven, Jorge
    Valiente, Manuel
    Sanchez-Martinez, Melchor
    Bosch-Barrera, Joaquim
    Menendez, Javier A.
    FOOD AND CHEMICAL TOXICOLOGY, 2018, 116 : 161 - 172
  • [47] Cooperative roles for Aiolos and STAT3 in TH17 differentiation
    Moon, Sol C.
    Sreekumar, Bharath
    Rasheed, Mustafa N.
    Read, Kaitlin
    Powell, Michael Duane
    Oestreich, Kenneth J.
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [48] Synergistic transactivation of the sis-inducible element by STAT4/STAT3 heterodimer in cytokine signal cascade.
    Higashi, Takehiro
    Tsukada, Junichi
    Mizobe, Takamitsu
    Mouri, Fumihiko
    Matsuura, Ai
    Minami, Yasuhiro
    Yoshida, Yasuhiro
    Tanaka, Yoshiya
    BLOOD, 2006, 108 (11) : 332A - 333A
  • [49] Intratumoural expression of IL-6/STAT3, IL-17 and FOXP3 immune cells in the immunosuppressive tumour microenvironment of colorectal cancer Immune cells-positive for IL-6, STAT3, IL-17 and FOXP3 and colorectal cancer development
    Gulubova, Maya Vladova
    Chonov, Dimitur Chavdarov
    Ivanova, Koni Vancho
    Hristova, Mariyna Kostova
    Krasimirova-Ignatova, Maria Magdalena
    Vlaykova, Tatyana Ivanova
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2022, 36 (01) : 327 - 338
  • [50] STAT3 determines IL-4 signalling outcomes in naive T cells
    Deimel, Lachlan P.
    Li, Zheyi
    Roy, Sreeja
    Ranasinghe, Charani
    SCIENTIFIC REPORTS, 2021, 11 (01)